Please assess the completion status of the following clinical trial:

Trial Title: Hypertonic Saline Solution in Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age over 18 years old~* Heart failure according to Framingham criteria~* Episode of acute decompensation,with need of in-hospital treatment~* Presence of congestive phenomena~Exclusion Criteria:~* Patient denial~* Left-ventricle ejection fraction over 0,4, as measure by transthoracic echocardiography~* Rheumatic disease~* Restrictive cardiomyopathy~* Alcohol abuse~* Chronic obstructive pulmonary disease~* Cancer~* Pulmonary embolism during the last 6 months~* Surgical procedures or acute illness during the last 30 days~* Chronic or acute infection~* Any other circumstance that may hamper patient prognosis for the next 6 months~* Serum creatine over 3.0mg/dL~* Serum potassium over 5.5 mEqs/L~* Any specific condition associated to the acute episode of decompensation, such as new onset cardiac arrhythmias, heart ischemia, infection, etc.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): Group of patients that will receive hypertonic saline solution (NaCl 7,5%)
- B (Type: PLACEBO_COMPARATOR): Group of patients that will receive placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).